Dyslipidemia in obese cats

Domestic Animal Endocrinology

Volumn 35, Issue 3, 2008, Pages 290-299

  Jordan, E ^a   Kley, S ^a   Le, N A ^b   Waldron, M ^c   Hoenig, M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b EMORY UNIVERSITY   (United States)

^c NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Diabetes; Nuclear magnetic resonance; Ultracentrifugation

Indexed keywords

CHOLESTEROL; FATTY ACID; LIPOPROTEIN; PHOSPHOLIPID; PLASMA PROTEIN; TRIACYLGLYCEROL;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BODY WEIGHT; CAT; CAT DISEASE; DYSLIPIDEMIA; EATING; FAT INTAKE; FEMALE; MALE; METABOLISM; OBESITY; PHYSIOLOGY; RANDOMIZATION;

ANIMALS; BLOOD PROTEINS; BODY WEIGHT; CAT DISEASES; CATS; CHOLESTEROL; DIETARY FATS; DYSLIPIDEMIAS; EATING; FATTY ACIDS, NONESTERIFIED; FEMALE; LIPOPROTEINS; MALE; OBESITY; PHOSPHOLIPIDS; RANDOM ALLOCATION; TRIGLYCERIDES;

EID: 50149112796     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.domaniend.2008.05.008     Document Type: Article

References (68)

1. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
2. Wellen K.E., and Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112 (2003) 1785-1788
3. Despres J.P., Moorjani S., Lupien P.J., et al. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 10 (1990) 497-511
4. Denke M.A., Sempos C.T., and Grundy S.M. Excess body weight. An under-recognized contributor to dyslipidemia in white American women. Arch Intern Med 154 (1994) 401-410
5. Griffin B.A. Lipoprotein atherogenicity: an overview of current mechanisms. Proc Nutr Soc 58 (1999) 163-169
6. Freedman D.S., Otvos J.D., Jeyarajah E.J., et al. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol 18 (1998) 1046-1053
7. Goff Jr. D.C., D'Agostino Jr. R.B., Haffner S.M., et al. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism 54 (2005) 264-270
8. Murakami T., Michelagnoli S., Longhi R., et al. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler Thromb Vasc Biol 15 (1995) 1819-1828
9. Mackey R.H., Kuller L.H., Sutton-Tyrrell K., et al. Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study. Am J Cardiol 90 (2002) 71i-76i
10. Garvey W.T., Kwon S., Zheng D., et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 52 (2003) 453-462
11. de Graaf J., Hendriks J.C., Demacker P.N., et al. Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment. Arterioscler Thromb 13 (1993) 712-719
12. Sparrow C.P., Parthasarathy S., and Steinberg D. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J Biol Chem 264 (1989) 2599-2604
13. Berliner J.A., Navab M., Fogelman A.M., et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91 (1995) 2488-2496
14. Ginsberg H.N., Kris-Etherton P., Dennis B., et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol 18 (1998) 441-449
15. Mori T.A., Bao D.Q., Burke V., et al. Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 70 (1999) 817-825
16. Garg A., Bantle J.P., Henry R.R., et al. Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus. JAMA 271 (1994) 1421-1428
17. Ceriello A., Taboga C., Tonutti L., et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 106 (2002) 1211-1218
18. Evans M., Anderson R.A., Graham J., et al. Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus. Circulation 101 (2000) 1773-1779
19. Fard A., Tuck C.H., Donis J.A., et al. Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 20 (2000) 2039-2044
20. Rongen G.A., and Tack C.J. Triglycerides and endothelial function in type 2 diabetes. Eur J Clin Invest 31 (2001) 560-562
21. Heine R.J., Balkau B., Ceriello A., et al. What does postprandial hyperglycaemia mean?. Diabet Med 21 (2004) 208-213
22. Lund E.M., Armstrong P.J., Kirk C.A., et al. Prevalence and risk factor for obesity in adult cats from private US veterinary practices. J Appl Res Vet Med 3 (2005) 88-96
23. Panciera D.L., Thomas C.B., Eicker S.W., et al. Epizootiological patterns of diabetes-mellitus in cats-333 cases (1980-1986). JAVMA 197 (1990) 1504-1508
24. Hoenig M. Comparative aspects of diabetes mellitus in dogs and cats. Mol Cell Endocrinol 197 (2002) 221-229
25. Hoenig M. The cat as a model for human nutrition and disease. Curr Opin Clin Nutr Metab Care 9 (2006) 584-588
26. Hoenig M., Alexander S., Holson J., et al. Influence of glucose dosage on interpretation of intravenous glucose tolerance tests in lean and obese cats. J Vet Intern Med 16 (2002) 529-532
27. Hoenig M., Hall G., Ferguson D., et al. A feline model of experimentally induced islet amyloidosis. Am J Pathol 157 (2000) 2143-2150
28. Hoenig M., Wilkins C., Holson J.C., et al. Effects of obesity on lipid profiles in neutered male and female cats. Am J Vet Res 64 (2003) 299-303
29. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
30. Otvos J.D., Jeyarajah E.J., Bennett D.W., et al. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 38 (1992) 1632-1638
31. Otvos J.D., Jeyarajah E.J., and Bennett D.W. Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. Clin Chem 37 (1991) 377-386
32. Hoenig M., and Ferguson D.C. Impairment of glucose tolerance in hyperthyroid cats. J Endocrinol 121 (1989) 249-251
33. Nelson R.W., Himsel C.A., Feldman E.C., et al. Glucose tolerance and insulin response in normal-weight and obese cats. Am J Vet Res 51 (1990) 1357-1362
34. Bergman R.N., and Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab 11 (2000) 351-356
35. McLaughlin T., Abbasi F., Cheal K., et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139 (2003) 802-809
36. Hoenig M., Thomaseth K., Waldron M., et al. Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss. Am J Physiol Regul Integr Comp Physiol 292 (2007) R227-234
37. Hoenig M., Thomaseth K., Brandao J., et al. Assessment and mathematical modeling of glucose turnover and insulin sensitivity in lean and obese cats. Domest Anim Endocrinol 31 (2006) 373-389
38. Lewis G.F., Carpentier A., Adeli K., et al. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23 (2002) 201-229
39. Taskinen M.R. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 46 (2003) 733-749
40. Egusa G., Beltz W.F., Grundy S.M., et al. Influence of obesity on the metabolism of apolipoprotein B in humans. J Clin Invest 76 (1985) 596-603
41. Howard B.V., Egusa G., Beltz W.F., et al. Compensatory mechanisms governing the concentration of plasma low density lipoprotein. J Lipid Res 27 (1986) 11-20
42. Hoenig M., McGoldrick J.B., deBeer M., et al. Activity and tissue-specific expression of lipases and tumor-necrosis factor alpha in lean and obese cats. Domest Anim Endocrinol 30 (2006) 333-344
43. Panarotto D., Remillard P., Bouffard L., et al. Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner. Eur J Clin Invest 32 (2002) 84-92
44. Chirieac D.V., Chirieac L.R., Corsetti J.P., et al. Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production. Am J Physiol Endocrinol Metab 279 (2000) E1003-E1011
45. Haffner S.M., Lehto S., Ronnemaa T., et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234
46. Mahley R.W., and Ji Z.S. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res 40 (1999) 1-16
47. Syvanne M., and Taskinen M.R. Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet 350 Suppl. 1 (1997) SI20-SI23
48. Zammit V.A. Role of insulin in hepatic fatty acid partitioning: emerging concepts. Biochem J 314 Pt 1 (1996) 1-14
49. Austin M.A., Breslow J.L., Hennekens C.H., et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260 (1988) 1917-1921
50. Blake G.J., Otvos J.D., Rifai N., et al. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation 106 (2002) 1930-1937
51. Lamarche B., Tchernof A., Moorjani S., et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 95 (1997) 69-75
52. Williams P.T., Superko H.R., Haskell W.L., et al. Smallest LDL particles are most strongly related to coronary disease progression in men. Arterioscler Thromb Vasc Biol 23 (2003) 314-321
53. Li P., Zhu Z., Lu Y., et al. Metabolic and cellular plasticity in white adipose tissue II: role of peroxisome proliferator-activated receptor-alpha. Am J Physiol Endocrinol Metab 289 (2005) E617-E626
54. Hoenig M., Caffall Z., and Ferguson D. Triiodothyronine differentially regulates key metabolic factors in lean and obese cats. Domest Anim Endocrinol 34 (2008) 229-237
55. Wilkins C., Long Jr. R.C., Waldron M., et al. Assessment of the influence of fatty acids on indices of insulin sensitivity and myocellular lipid content by use of magnetic resonance spectroscopy in cats. Am J Vet Res 65 (2004) 1090-1099
56. Dreon D.M., Fernstrom H.A., Campos H., et al. Change in dietary saturated fat intake is correlated with change in mass of large low-density-lipoprotein particles in men. Am J Clin Nutr 67 (1998) 828-836
57. St-Onge M.P., Aban I., Bosarge A., et al. Snack chips fried in corn oil alleviate cardiovascular disease risk factors when substituted for low-fat or high-fat snacks. Am J Clin Nutr 85 (2007) 1503-1510
58. Woodman R.J., Mori T.A., Burke V., et al. Docosahexaenoic acid but not eicosapentaenoic acid increases LDL particle size in treated hypertensive type 2 diabetic patients. Diabetes Care 26 (2003) 253
59. Kratz M., Gulbahce E., von Eckardstein A., et al. Dietary mono- and polyunsaturated fatty acids similarly affect LDL size in healthy men and women. J Nutr 132 (2002) 715-718
60. Davy B.M., Davy K.P., Ho R.C., et al. High-fiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middle-aged and older men. Am J Clin Nutr 76 (2002) 351-358
61. Gou L., Fu M., Xu Y., et al. Alterations of high-density lipoprotein subclasses in endogenous hypertriglyceridemia. Am Heart J 150 (2005) 1039-1045
62. Tian L., Jia L., Mingde F., et al. Alterations of high density lipoprotein subclasses in obese subjects. Lipids 41 (2006) 789-796
63. Rashid S., Uffelman K.D., and Lewis G.F. The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states. J Diabetes Complications 16 (2002) 24-28
64. Guerci B., Verges B., Durlach V., et al. Relationship between altered postprandial lipemia and insulin resistance in normolipidemic and normoglucose tolerant obese patients. Int J Obes Relat Metab Disord 24 (2000) 468-478
65. Musso G., Gambino R., De Michieli F., et al. Retraction: the postprandial phase as a link between systemic lipid peroxidation and liver injury in NASH. Am J Gastroenterol (2006)
66. Belkner J., Stender H., Holzhutter H.G., et al. Macrophage cholesteryl ester hydrolases and hormone-sensitive lipase prefer specifically oxidized cholesteryl esters as substrates over their non-oxidized counterparts. Biochem J 352 (2000) 125-133
67. Karpe F., Steiner G., Uffelman K., et al. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 106 (1994) 83-97
68. Holzl B., Paulweber B., Sandhofer F., et al. Hypertriglyceridemia and insulin resistance. J Intern Med 243 (1998) 79-82